SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
EPIDEMIOLOGY AND PREVENTION OF MPOX AND SARS-CoV-2
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
12 of
12
|
INTRODUCTIONS (Part 1)
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Francois Dabis
University of Bordeaux, Bordeaux, France
EFFECTIVENESS OF SMALLPOX VACCINATION TO PREVENT MPOX IN MILITARY PERSONNEL (ABSTRACT
207)
Boghuma K. Titanji
Emory University, Atlanta, GA, United States
IMPACT OF VACCINATION ON MPOX INCIDENCE IN MSM ON PrEP IN THE ANRS 174 DOXYVAC TRIAL (ABSTRACT
208)
Jade Ghosn
University of Paris Cité, Paris, France
HOUSEHOLD TRANSMISSION OF MPOX TO CHILDREN AND ADOLESCENTS (ABSTRACT
209)
Darpun Sachdev
California Department of Public Health, San Francisco, CA, United States
ASSOCIATION BETWEEN OBSERVED MASKING AND SARS-CoV-2 PRESENCE IN SCHOOL WASTEWATER (ABSTRACT
210)
Rebecca Fielding-Miller
University of California San Diego, San Diego, CA, United States
QUESTIONS AND ANSWERS (Part 1)
Francois Dabis
University of Bordeaux, Bordeaux, France
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
INTRODUCTIONS (Part 2)
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Francois Dabis
University of Bordeaux, Bordeaux, France
VARIABLE REDUCTIONS IN SARS-CoV-2 VARIANT IMPORTATIONS FOLLOWING TRAVEL RESTRICTIONS (ABSTRACT
211)
Angela McLaughlin
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
INTERVENTION EFFICACY ON COVID-19 TESTING AND VACCINATION IN PEOPLE WHO INJECT DRUGS (ABSTRACT
212)
Angela R. Bazzi
University of California San Diego, La Jolla, CA, United States
CLUSTER-RANDOMIZED TRIAL COMPARING TWO SARS-CoV-2 TESTING MODELS IN AFRICA (ABSTRACT
213)
Nilesh Bhatt
Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, United States
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION (ABSTRACT
214)
Jing Sun
The Johns Hopkins University, Baltimore, MD, United States
QUESTIONS AND ANSWERS (Part 2)
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Francois Dabis
University of Bordeaux, Bordeaux, France
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
12 of
12
|
